NEOGEN DEVELOPMENTS
Timeline
23 events since 2008Board
Capital
Filings
Financial
2008201020122014201620182020202220242026
2020
- General meeting, 30-06-2020
- Accounting effect, 01-01-2020
- The deed holds 3 more points.
Annual accounts 2019 filed PDFabbreviated format · 17 days before the deadline
- Neogen NV holds all the shares, mentioned twice in the deed
- Alter Pharma NV holds all the shares, mentioned twice in the deed
- Capital, €5,255,197.80, 9,807 shares
- Accounting effect, 01-01-2020
- Permanent representative, Julie Delforge
- The deed holds 12 more points.
2 directors appointed, 2 resignationsResignations: GRNR Invest BV and Alter Pharma NV · Permanent representatives: Thomas Jacobsen, Pieter Van Rompay and Ivo Peeters · Appointments: Jacobsen Management BV and HFS BV · General meeting of 12-02-20209 points ▸
- General meeting, 12-02-2020
- Director resignation, GRNR Invest BV
- Director resignation, Alter Pharma NV
- Permanent representative, Thomas Jacobsen, mentioned twice in the deed
- Permanent representative, Pieter Van Rompay
- Director appointment, Jacobsen Management BV
- Director appointment, HFS BV
- Permanent representative, Ivo Peeters
- Board meeting, 12-02-2020
- The deed holds 2 more points.
2019
Weakest financial year net -€76,722 The net result drops to -€76,722, the lowest from 2010 to 2019.
Annual accounts 2018 filed PDFfull format · 22 days before the deadline
2018
Liquidity more than triples current ratio 3.59 The current ratio rises from 1.12 to 3.59. Short-term debt falls from €2.5m to €258,824.
Annual accounts 2018 filed PDFfull format · 5 days before the deadline
2017
Annual accounts 2017 filed PDFfull format · 8 days late
Highest result from 2010 to 2019 net €84,367 ▲89.7% The net result of €84,367 is the highest of those years.
2016
Annual accounts 2016 filed PDFfull format · 6 days before the deadline
Equity above €200,000 equity €225,566 ▲24.6% After 3 profitable years in a row, equity reaches €225,566.
2015
Annual accounts 2015 filed PDFfull format · 12 days before the deadline
Equity above €150,000 equity €181,102 ▲54.4% After 2 profitable years in a row, equity reaches €181,102.
2014
Annual accounts 2014 filed PDFfull format · 3 days before the deadline
Back to profit net €70,305 The net result is €70,305, after one loss-making year.
Equity above €100,000 equity €117,325 ▲150% Equity rises from €47,020 to €117,325.
2013
Annual accounts 2013 filed PDFfull format · on the deadline day
2012
Annual accounts 2012 filed PDFabbreviated format · 6 days before the deadline
2011
Annual accounts 2011 filed PDFabbreviated format · 28 days late
Back to profit net €2,728 The net result is €2,728, after one loss-making year.
2010
Annual accounts 2010 filed PDFabbreviated format · 34 days before the deadline
2008
Incorporation PDF12 publications in the Belgian Official Gazette, the last on 23-07-2020
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank